saline IV

DRUG4 trials

Sponsors

Embera NeuroTherapeutics, Inc., Xu Siqi, Rhode Island Hospital, Alexandria University

Conditions

Arthroplasty, Replacement, KneeCancer of PancreasCocaine Use DisorderDexmedetomidineERASLidocaineNatural Killer Cell Cytokine ProductionNausea and Vomiting, Postoperative

Phase 1

A Study of Metyrapone and Oxazepam Combination Product (EMB-001) and Cocaine

CompletedNCT02856854

Embera NeuroTherapeutics, Inc.Cocaine Use Disorder

Start: 2016-07-31End: 2017-07-25Updated: 2017-08-01

Phase 4

Systemic Lidocaine Versus Ultrasound-guided Adductor Canal Block for Patients Undergoing Total Knee Arthroplasty

CompletedNCT04828083

Rhode Island HospitalArthroplasty, Replacement, Knee, Total Knee Arthroplasty

Start: 2021-03-01End: 2024-09-02Updated: 2026-06-15

Unknown Phase

Effect of Lidocaine Plus Dexmedetomidine Infusion on PONV

CompletedNCT03788018

Xu SiqiDexmedetomidine, Lidocaine, Nausea and Vomiting, Postoperative

Start: 2018-01-01End: 2018-12-01Updated: 2019-01-08

Lidocaine Infusion With ERAS Protocol for Pancreatic Cancer Surgery: Effect on Pain and Patient Immunity.

CompletedNCT05470166

Alexandria UniversityCancer of Pancreas, ERAS, Lidocaine +1

Start: 2022-04-20End: 2024-04-01Updated: 2024-08-21